Exercise dose and long-term cardiovascular outcomes.
A population-informed analysis of structured exercise intensity, frequency, and projected risk trajectory.
View summaryClinical Evidence
Built on peer-reviewed science and real-world implementation.
MHF is built on peer-reviewed research, real-world clinical implementation, patent-pending platform development, and a responsible pathway toward future regulated clinical decision support.
Peer-reviewed Publications
The evidence base behind the platform.
Plain-language summaries of published research from Dr. Alter and collaborators on cardiometabolic outcomes, structured exercise dose, and population health.
Behaviour change in cardiometabolic prevention.
Real-world engagement patterns across 3,000+ patients in clinical and community settings.
View summaryMeasurement frameworks for exercise-based prevention.
Why participation metrics fall short and what prevention infrastructure should actually capture.
View summaryPatent-pending Platform
Proprietary exercise-dose-to-projection methodology.
MHF's platform is patent-pending across its exercise interpretation, projection logic, and reporting framework. The methodology has been refined over years of real-world clinical implementation and is grounded in published cardiometabolic outcomes literature.
Detailed methodology and conversion logic are protected and not publicly disclosed.
- Patent-pending. Exercise-dose-to-projection methodology.
- Cardiology-designed. Built by a practicing cardiologist.
- Population-informed. Grounded in published outcomes research.
- Implementation-tested. Refined across 3,000+ patients.
- Reporting-ready. Aggregate dashboards for partners.
Real-world Implementation
8+ years of clinical implementation experience.
MHF was refined through real-world implementation across clinical, community, employer, and research settings, including the operational learning that emerged from the Milton Cardiac Care program founded by Dr. Alter in 2010.
Setting 01
Clinical & cardiology programs
Integrated into a regional cardiology program serving 3,000+ cardiometabolic patients across community and hospital settings.
Setting 02
Employer & benefits
Implementation partnerships exploring engagement, activation, and projected value for organizational populations.
Setting 03
Research & quality improvement
Collaborations supporting validation, reporting frameworks, and evidence generation.
Regulatory Pathway
Building responsibly toward regulated clinical decision support.
MHF is currently operating as a cardiology-designed, educational, population-informed platform in an early implementation and evidence-generation phase. We are building toward regulated clinical decision-support pathways, including FDA and Health Canada SaMD validation.
MHF is not currently marketed as FDA-approved or Health Canada-approved clinical decision support. We are building the evidence, implementation experience, and regulatory strategy required for responsible future clinical use.
Collaborate With Us
Research, regulatory & clinical collaboration opportunities.
We welcome conversations with research institutions, regulatory partners, and clinical groups interested in shaping the evidence base for responsible digital prevention.